UniProt ID | CYLD_MOUSE | |
---|---|---|
UniProt AC | Q80TQ2 | |
Protein Name | Ubiquitin carboxyl-terminal hydrolase CYLD | |
Gene Name | Cyld | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 952 | |
Subcellular Localization |
Cytoplasm. Cytoplasm, perinuclear region. Cytoplasm, cytoskeleton. Cell membrane Peripheral membrane protein Cytoplasmic side . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Cytoplasm, cytoskeleton, spindle . Cytoplasm, cytoskel |
|
Protein Description | Deubiquitinase that specifically cleaves 'Lys-63'-linked polyubiquitin chains. Has endodeubiquitinase activity. Plays an important role in the regulation of pathways leading to NF-kappa-B activation. Contributes to the regulation of cell survival, proliferation and differentiation via its effects on NF-kappa-B activation. Negative regulator of Wnt signaling. Inhibits HDAC6 and thereby promotes acetylation of alpha-tubulin and stabilization of microtubules. Plays a role in the regulation of microtubule dynamics, and thereby contributes to the regulation of cell proliferation, cell polarization, cell migration, and angiogenesis. Required for normal cell cycle progress and normal cytokinesis. Inhibits nuclear translocation of NF-kappa-B (By similarity). Plays a role in the regulation of inflammation and the innate immune response, via its effects on NF-kappa-B activation. Dispensable for the maturation of intrathymic natural killer cells, but required for the continued survival of immature natural killer cells. Negatively regulates TNFRSF11A signaling and osteoclastogenesis. Involved in the regulation of ciliogenesis, allowing ciliary basal bodies to migrate and dock to the plasma membrane; this process does not depend on NF-kappa-B activation. [PubMed: 25134987 Also able to remove linear ('Met-1'-linked) polyubiquitin chains to regulate innate immunity: recruited to the LUBAC complex and, together with OTULIN, restricts linear polyubiquitin formation on RIPK2 in response to NOD2 stimulation (By similarity] | |
Protein Sequence | MSSGLWSQEKVTSPYWEERIFYLLLQECSVTDKQTQKLLKVPKGSIGQYIQDRSVGHSRVPSTKGKKNQIGLKILEQPHAVLFVDEKDVVEINEKFTELLLAITNCEERLSLFRNRLRLSKGLQVDVGSPVKVQLRSGEEKFPGVVRFRGPLLAERTVSGIFFGVELLEEGRGQGFTDGVYQGKQLFQCDEDCGVFVALDKLELIEDDDNGLESDFAGPGDTMQVEPPPLEINSRVSLKVGESTESGTVIFCDVLPGKESLGYFVGVDMDNPIGNWDGRFDGVQLCSFASVESTILLHINDIIPDSVTQERRPPKLAFMSRGVGDKGSSSHNKPKVTGSTSDPGSRNRSELFYTLNGSSVDSQQSKSKNPWYIDEVAEDPAKSLTEMSSDFGHSSPPPQPPSMNSLSSENRFHSLPFSLTKMPNTNGSMAHSPLSLSVQSVMGELNSTPVQESPPLPISSGNAHGLEVGSLAEVKENPPFYGVIRWIGQPPGLSDVLAGLELEDECAGCTDGTFRGTRYFTCALKKALFVKLKSCRPDSRFASLQPVSNQIERCNSLAFGGYLSEVVEENTPPKMEKEGLEIMIGKKKGIQGHYNSCYLDSTLFCLFAFSSALDTVLLRPKEKNDIEYYSETQELLRTEIVNPLRIYGYVCATKIMKLRKILEKVEAASGFTSEEKDPEEFLNILFHDILRVEPLLKIRSAGQKVQDCNFYQIFMEKNEKVGVPTIQQLLEWSFINSNLKFAEAPSCLIIQMPRFGKDFKLFKKIFPSLELNITDLLEDTPRQCRICGGLAMYECRECYDDPDISAGKIKQFCKTCSTQVHLHPRRLNHSYHPVSLPKDLPDWDWRHGCIPCQKMELFAVLCIETSHYVAFVKYGKDDSAWLFFDSMADRDGGQNGFNIPQVTPCPEVGEYLKMSLEDLHSLDSRRIQGCARRLLCDAYMCMYQSPTMSLYK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSSGLWSQE ------CCCCCCCCC | 32.87 | 28066266 | |
3 | Phosphorylation | -----MSSGLWSQEK -----CCCCCCCCCC | 36.28 | 28066266 | |
7 | Phosphorylation | -MSSGLWSQEKVTSP -CCCCCCCCCCCCCC | 33.24 | 25338131 | |
12 | Phosphorylation | LWSQEKVTSPYWEER CCCCCCCCCCHHHHH | 34.74 | 28066266 | |
13 | Phosphorylation | WSQEKVTSPYWEERI CCCCCCCCCHHHHHH | 20.98 | 25266776 | |
15 | Phosphorylation | QEKVTSPYWEERIFY CCCCCCCHHHHHHHH | 25.81 | 18515860 | |
129 | Phosphorylation | GLQVDVGSPVKVQLR CCCCCCCCCEEEEEC | 26.77 | 28066266 | |
328 | Phosphorylation | RGVGDKGSSSHNKPK CCCCCCCCCCCCCCC | 34.11 | 21183079 | |
337 | O-linked_Glycosylation | SHNKPKVTGSTSDPG CCCCCCCCCCCCCCC | 31.38 | 30016717 | |
339 | Phosphorylation | NKPKVTGSTSDPGSR CCCCCCCCCCCCCCC | 18.51 | 29899451 | |
340 | Phosphorylation | KPKVTGSTSDPGSRN CCCCCCCCCCCCCCC | 38.19 | 30482847 | |
341 | Phosphorylation | PKVTGSTSDPGSRNR CCCCCCCCCCCCCCH | 43.43 | 25521595 | |
345 | O-linked_Glycosylation | GSTSDPGSRNRSELF CCCCCCCCCCHHHEE | 31.60 | 30016717 | |
349 | Phosphorylation | DPGSRNRSELFYTLN CCCCCCHHHEEEEEC | 42.05 | 29899451 | |
358 | Phosphorylation | LFYTLNGSSVDSQQS EEEEECCCCCCCCCC | 26.56 | 29550500 | |
359 | Phosphorylation | FYTLNGSSVDSQQSK EEEECCCCCCCCCCC | 31.20 | 28973931 | |
383 | Phosphorylation | VAEDPAKSLTEMSSD HHCCHHHHHHHHCCC | 42.50 | 26643407 | |
385 | Phosphorylation | EDPAKSLTEMSSDFG CCHHHHHHHHCCCCC | 36.41 | 26643407 | |
388 | Phosphorylation | AKSLTEMSSDFGHSS HHHHHHHCCCCCCCC | 22.11 | 26643407 | |
389 | Phosphorylation | KSLTEMSSDFGHSSP HHHHHHCCCCCCCCC | 35.33 | 26643407 | |
394 | Phosphorylation | MSSDFGHSSPPPQPP HCCCCCCCCCCCCCC | 44.94 | 25266776 | |
395 | Phosphorylation | SSDFGHSSPPPQPPS CCCCCCCCCCCCCCC | 35.43 | 25266776 | |
402 | Phosphorylation | SPPPQPPSMNSLSSE CCCCCCCCCCCCCCC | 36.96 | 29472430 | |
414 | Phosphorylation | SSENRFHSLPFSLTK CCCCCCCCCCCCCEE | 34.72 | 26824392 | |
418 | Phosphorylation | RFHSLPFSLTKMPNT CCCCCCCCCEECCCC | 32.94 | 21082442 | |
420 | Phosphorylation | HSLPFSLTKMPNTNG CCCCCCCEECCCCCC | 24.89 | 21082442 | |
543 | Phosphorylation | RPDSRFASLQPVSNQ CCCCCCCCCCCCCHH | 25.48 | 30352176 | |
548 | Phosphorylation | FASLQPVSNQIERCN CCCCCCCCHHHHHHH | 29.69 | 30352176 | |
556 | Phosphorylation | NQIERCNSLAFGGYL HHHHHHHHHCCCCHH | 25.38 | 29899451 | |
623 | Ubiquitination | VLLRPKEKNDIEYYS HHCCCCCCCCCCCHH | 67.08 | 22790023 | |
623 (in isoform 2) | Ubiquitination | - | 67.08 | 22790023 | |
626 (in isoform 2) | Ubiquitination | - | 5.25 | - | |
717 | Ubiquitination | FYQIFMEKNEKVGVP CCHHHHHCCCCCCCC | 59.63 | 22790023 | |
717 (in isoform 2) | Ubiquitination | - | 59.63 | 22790023 | |
720 (in isoform 2) | Ubiquitination | - | 54.40 | - | |
915 | Phosphorylation | VGEYLKMSLEDLHSL HHHHHHCCHHHHHHC | 27.33 | 26370283 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
414 | S | Phosphorylation | Kinase | IKBKE | Q14164 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CYLD_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CYLD_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SQSTM_MOUSE | Sqstm1 | physical | 18382763 | |
SQSTM_MOUSE | Sqstm1 | physical | 18174161 | |
RIPK1_MOUSE | Ripk1 | physical | 17981138 | |
ITCH_MOUSE | Itch | physical | 22057290 | |
FOS_MOUSE | Fos | physical | 21478324 | |
JUN_MOUSE | Jun | physical | 21478324 | |
NEMO_MOUSE | Ikbkg | physical | 22037414 | |
ITCH_MOUSE | Itch | physical | 23782702 | |
NEMO_MOUSE | Ikbkg | physical | 23825957 | |
UBC_HUMAN | UBC | physical | 18174161 | |
RIPK2_MOUSE | Ripk2 | physical | 26834734 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-414, AND MASSSPECTROMETRY. |